Get started
Author

Selamawit Addissie

Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
2018 · Ronit Mazor, Emily M. King, et al. · Proceedings of the National Academy of Sciences · 49
PDF
Dual B- and T-cell de-immunization of recombinant immunotoxin targeting mesothelin with high cytotoxic activity
2016 · Ronit Mazor, Masanori Onda, et al. · Oncotarget · 45
PDF
Elimination of murine and human T-cell epitopes in recombinant immunotoxin eliminates neutralizing and anti-drug antibodies in vivo
2015 · Ronit Mazor, Devorah Crown, et al. · Cellular and Molecular Immunology · 42
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
2015 · Ronit Mazor, Jingli Zhang, et al. · Molecular Cancer Therapeutics · 36
Cellular Immunotherapy of Canine Cancer
2018 · Selamawit Addissie, Hans Klingemann · Veterinary Sciences · 29
PDF
Role of HLA-DP in the Presentation of Epitopes from the Truncated Bacterial PE38 Immunotoxin
2016 · Ronit Mazor, Selamawit Addissie, et al. · The AAPS Journal · 5
PDF
Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease
2026 · Christoph Weigel, Haley L. Klimaszewski, et al. · Blood Neoplasia · 4
Epigenetic Activation of the EBV Protein Kinase Determines Antiviral Drug Response in Central Nervous System Lymphoma
2024 · Christoph Weigel, Haley L Klimaszewski, et al. · medRxiv
PDF
Abstract LB422: Specific activation of the Epstein-Barr Virus BGLF4 locus via lowered DNA methylation in EBV-associated CNS lymphoproliferative disease
2024 · Christoph Weigel, Haley L. Klimaszewski, et al. · Cancer Research
Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease
2023 · Haley L. Klimaszewski, Christoph Weigel, et al. · Blood
Supplementary Tables S1-S2 and Supplementary Figure S1 from Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
2023 · Ronit Mazor, Jingli Zhang, et al.
Data from Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
2023 · Ronit Mazor, Jingli Zhang, et al.
Data from Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
2023 · Ronit Mazor, Jingli Zhang, et al.
Assessing food insecurity among hospitalized patients at an NCI-designated comprehensive cancer center
2021 · Marium Husain, Electra Paskett, et al. · Research Square
PDF
Works count: 14
Citation count: 210
H-index: 5
I10-index: 5
Year
Topic
Type